Potential impact of 2018 Korean Society of Hypertension guidelines on Korean population: a population-based cohort study
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Background: The Korean Society of Hypertension (KSH) revised the local guidelines for hypertension in 2018. The present study sought to evaluate the potential impact of the 2018 KSH guidelines on hypertension management status among the Korean population in terms of prevalence of hypertension, antihypertensive medical treatment recommendations, and control status in Korean adults. Methods: We used data from the Korea National Health and Nutrition Examination Survey to estimate the number and percentage of Korean adults who have hypertension according to blood pressure (BP) classification, are recommended to receive antihypertensive medical treatment, and are receiving medical treatment and have BP in the optimal range according to the new recommendations. Adults aged 30 years or older who participated in the survey between 2013 and 2015 were selected for this study. Results: The prevalence of hypertension was 30.5% among Korean adults aged 30 years or older. The percentage of subjects who are recommended to be treated with antihypertensive medications substantially increased from 32.5 to 37.8%, which translates to 1.6 million adults. Among the hypertensive patients who were receiving medical treatment, 38.6% were shown to have adequate BP levels as recommended by the 2018 KSH guidelines compared with 51.8% according to the previous 2013 guidelines. Conclusions: The present study reports the potential impact of the 2018 KSH guidelines on the prevalence of hypertension, antihypertensive medical treatment recommendations, and control status for Korean adults. The 2018 KSH guidelines recommend more intensive BP control compared with previous guidelines. This study suggests that there is large scope for improvement in hypertension management in the Korean population.
Abstract
Background: The Korean Society of Hypertension (KSH) revised the local guidelines for hypertension in 2018. The present study sought to evaluate the potential impact of the 2018 KSH guidelines on hypertension management status among the Korean population in terms of prevalence of hypertension, antihypertensive medical treatment recommendations, and control status in Korean adults. Methods: We used data from the Korea National Health and Nutrition Examination Survey to estimate the number and percentage of Korean adults who have hypertension according to blood pressure (BP) classification, are recommended to receive antihypertensive medical treatment, and are receiving medical treatment and have BP in the optimal range according to the new recommendations. Adults aged 30 years or older who participated in the survey between 2013 and 2015 were selected for this study. Results: The prevalence of hypertension was 30.5% among Korean adults aged 30 years or older. The percentage of subjects who are recommended to be treated with antihypertensive medications substantially increased from 32.5 to 37.8%, which translates to 1.6 million adults. Among the hypertensive patients who were receiving medical treatment, 38.6% were shown to have adequate BP levels as recommended by the 2018 KSH guidelines compared with 51.8% according to the previous 2013 guidelines. Conclusions: The present study reports the potential impact of the 2018 KSH guidelines on the prevalence of hypertension, antihypertensive medical treatment recommendations, and control status for Korean adults. The 2018 KSH guidelines recommend more intensive BP control compared with previous guidelines. This study suggests that there is large scope for improvement in hypertension management in the Korean population.
참고문헌 (24)
- Forouzanfar MH, "Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm hg, 1990-2015", JAMA, 317(2), pp.165~182 (2017)
- Danaei G, "National, regional, and global trends in systolic blood pressure since 1980: Systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants", Lancet, 377(9765), pp.568~577 (2011)
- Lewington S, "Age-specific relevance of usual blood pressure to vascular mortality : a metaanalysis of individual data for one million adults in 61 prospective studies", Lancet, 360(9349), pp.1903~1913 (2002)
- Group SR, "A randomized trial of intensive versus standard blood-pressure control", N Engl J Med, 373(22), pp.2103~2116 (2015)
- Whelton PK, "2017ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Muntner P, "Potential U.S. Population Impact of the 2017 ACC", AHA high blood pressure guideline, 2018, pp.71(2), 109~118
- Lee JH, "Blood pressure control and cardiovascular outcomes : realworld implications of the 2017 ACC", AHA hypertension guideline, 2018, pp.8(1), 13155~
- Ishag Adam, "Red cell distribution width and preeclampsia: a systematic review and meta-analysis", Clinical Hypertension, 25(4), pp.16~23 (2019), 대한고혈압학회[DOI]
- Hae-Young Lee, "2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension", Clinical Hypertension, 25(4), pp.51~74 (2019), 대한고혈압학회[DOI]
- Kwang-Il Kim, "2018 Korean society of hypertension guidelines for the management of hypertension: part III-hypertension in special situations", Clinical Hypertension, 25(4), pp.75~88 (2019), 대한고혈압학회[DOI]
- Kweon S, "Data resource profile : the Korea National Health and nutrition examination survey(KNHANES)", Int J Epidemiol, 43(1), pp.69~77 (2014)
- Kang SH, "Prevalence, awareness, treatment, and control of hypertension in Korea", Sci Rep, 9(1), pp.10970~ (2019)
- Reboussin DM, "Systematic Review for the 2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Reboussin DM, "Systematic Review for the 2017 ACC", AHA, ABC, pp.ACPM, AGS[DOI]
- Bangalore S, "Optimal systolic blood pressure target after SPRINT : insights from a network meta-analysis of randomized trials", Am J Med, 130(6), pp.707~719 (2017)
- Thomopoulos C, "Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels -updated overview and meta-analyses of randomized trials", J Hypertens, 34(4), pp.613~622 (2016)
- Williams B, "2018 ESC", ESH guidelines for the management of arterial hypertension, 2018, pp.39(33), 3021~3104
- Korean Society H, Hypertension epidemiology research working G, "Korea hypertension fact sheet 2018", Clin Hypertens, 24, pp.13~ (2018)
- Choi YJ, "Reconsidering the cut-off diastolic blood pressure for predicting cardiovascular events : a nationwide population-based study from Korea", Eur Heart J, 40(9), pp.724~731 (2019)
- Franklin SS, "Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study", Circulation, 103(9), pp.1245~1249 (2001)
- Banegas JR, "Relationship between clinic and ambulatory blood-pressure measurements and mortality", N Engl J Med, 378(16), pp.1509~1520 (2018)
- Myers MG, "Measurement of blood pressure in the office : recognizing the problem and proposing the solution", Hypertension, 55(2), pp.195~200 (2010)
- Parati G, "European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring", J Hypertens, 32(7), pp.1359~1366 (2014)
- O’Brien E, "European Society of Hypertension position paper on ambulatory blood pressure monitoring", J Hypertens, 31(9), pp.1731~1768 (2013)